These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 35832648)

  • 1. Identification of Survival Risk and Immune-Related Characteristics of Kidney Renal Clear Cell Carcinoma.
    Wu X; Liang Y; Chen X; Long X; Xu W; Liu L; Wang B; Zou X
    J Immunol Res; 2022; 2022():6149369. PubMed ID: 35832648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GRAMD1A Is a Biomarker of Kidney Renal Clear Cell Carcinoma and Is Associated with Immune Infiltration in the Tumour Microenvironment.
    Liu Y; Fu S; Zhang Z; Wang S; Cheng X; Li Z; Ding Y; Sun T; Ma M
    Dis Markers; 2022; 2022():5939021. PubMed ID: 35860689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated CDC45 Expression Predicts Poorer Overall Survival Prognoses and Worse Immune Responses for Kidney Renal Clear Cell Carcinoma via Single-Cell and Bulk RNA-Sequencing.
    Zhang X; Zhou J; Wang Y; Wang X; Zhu B; Xing Q
    Biochem Genet; 2024 Jun; 62(3):1502-1520. PubMed ID: 37642814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cuproptosis status affects treatment options about immunotherapy and targeted therapy for patients with kidney renal clear cell carcinoma.
    Zhang G; Chen X; Fang J; Tai P; Chen A; Cao K
    Front Immunol; 2022; 13():954440. PubMed ID: 36059510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KCNN4 is a potential prognostic marker and critical factor affecting the immune status of the tumor microenvironment in kidney renal clear cell carcinoma.
    Chen S; Wang C; Su X; Dai X; Li S; Mo Z
    Transl Androl Urol; 2021 Jun; 10(6):2454-2470. PubMed ID: 34295732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical significance, immune infiltration, and tumor mutational burden of angiogenesis-associated lncRNAs in kidney renal clear cell carcinoma.
    Zhang W; Liu Z; Wang J; Geng B; Hou W; Zhao E; Li X
    Front Immunol; 2022; 13():934387. PubMed ID: 35958561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive Analysis of N6-Methyladenosine-Related IncRNAs Prognostic Signature and the Associated Immune Infiltrates in Kidney Renal Clear Cell Carcinoma.
    Chen X; Wang L; Tu J; Pan X; Li Y; Yin H; Wang M; Yuan X
    Crit Rev Eukaryot Gene Expr; 2022; 32(1):79-98. PubMed ID: 35377983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and validation of a novel signature based on macrophage marker genes for predicting prognosis and drug response in kidney renal clear cell carcinoma by integrated analysis of single cell and bulk RNA sequencing.
    Chen X; Zhang Z; Qin Z; Zhu X; Wang K; Kang L; Li C; Wang H
    Aging (Albany NY); 2024 Mar; 16(6):5676-5702. PubMed ID: 38517387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the basement membrane in kidney renal clear cell carcinoma to guide clinical therapy.
    Xiong X; Chen C; Yang J; Ma L; Wang X; Zhang W; Yuan Y; Peng M; Li L; Luo P
    Front Oncol; 2022; 12():1024956. PubMed ID: 36439501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive analysis of MFN2 as a prognostic biomarker associated with immune cell infiltration in renal clear cell carcinoma.
    Cheng L; Wang Z; Nie L; Yang C; Huang H; Lin J; Zhuo D
    Int Immunopharmacol; 2022 Oct; 111():109169. PubMed ID: 36007389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COLGALT1 is a potential biomarker for predicting prognosis and immune responses for kidney renal clear cell carcinoma and its mechanisms of ceRNA networks.
    Liu S; Yu Y; Wang Y; Zhu B; Han B
    Eur J Med Res; 2022 Jul; 27(1):122. PubMed ID: 35842702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma.
    Sun K; Chen RX; Li JZ; Luo ZX
    Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cuproptosis-Related 4-Gene Risk Model for Predicting Immunotherapy Drug Response and Prognosis of Kidney Renal Clear Cell Carcinoma.
    Guo JS; Ding H; Wu PY; Xin ZY; Li JX; Jo HS; Ma ZH
    Chin Med Sci J; 2023 Sep; 38(3):191-205. PubMed ID: 37503721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and Verification of Tumor Immune Microenvironment-Related Prognostic Genes in Kidney Renal Clear Cell Carcinoma.
    Kong G; Wang Y; Huang Y; Shi Z
    Biomed Res Int; 2022; 2022():5563668. PubMed ID: 35127943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD72, a new immune checkpoint molecule, is a novel prognostic biomarker for kidney renal clear cell carcinoma.
    Tian L; Wang Y; Zhang Z; Feng X; Xiao F; Zong M
    Eur J Med Res; 2023 Nov; 28(1):531. PubMed ID: 37980541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comprehensive analysis of essential meiotic endonuclease 1 to prognosis and immune infiltration in kidney renal clear cell carcinoma.
    Li HD; Ma HX; Ma JH; Kong SP; Zhao ST; Fan SQ; Qin F; Ma JG
    Eur Rev Med Pharmacol Sci; 2024 Jan; 28(2):584-602. PubMed ID: 38305603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disulfidptosis-associated LncRNA signature predicts prognosis and immune response in kidney renal clear cell carcinoma.
    Xu K; Li D; Ji K; Zhang Y; Zhang M; Zhou H; Hou X; Jiang J; Zhang Z; Dai H; Sun H
    Biol Direct; 2024 Aug; 19(1):71. PubMed ID: 39175011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of a Lactate-Related Prognostic Signature for Predicting Prognosis, Tumor Microenvironment, and Immune Response in Kidney Renal Clear Cell Carcinoma.
    Sun Z; Tao W; Guo X; Jing C; Zhang M; Wang Z; Kong F; Suo N; Jiang S; Wang H
    Front Immunol; 2022; 13():818984. PubMed ID: 35250999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supervised Learning and Multi-Omics Integration Reveals Clinical Significance of Inner Membrane Mitochondrial Protein (IMMT) in Prognostic Prediction, Tumor Immune Microenvironment and Precision Medicine for Kidney Renal Clear Cell Carcinoma.
    Chen CC; Chu PY; Lin HY
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ZEB family is a prognostic biomarker and correlates with anoikis and immune infiltration in kidney renal clear cell carcinoma.
    Lin S; Chen Q; Tan C; Su M; Min L; Ling L; Zhou J; Zhu T
    BMC Med Genomics; 2024 Jun; 17(1):153. PubMed ID: 38840097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.